Filter News

NeuroMed Technologies Inc. To Report Financial Results For The Quarter Ended September 30, 2005

Published: Nov 03, 2005

EMERYVILLE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) , a biotechnology company engaged in the business of acquiring and developing central nervous system related drug candidates, announced today it will release its first quarter financial results, for the quarter ended September 30, 2005, on November 10, 2005.

In conjunction with the release of financial results, the company will host a conference call, which will be simultaneously broadcast over the Internet. Hosting the call will be Paul E. Freiman, President and Chief Executive Officer, and Jonathan R. Wolter, Vice President and Chief Financial Officer. The details for the call are as follows:

Live Call: Date: Thursday, November 10, 2005 Time: 10:00 a.m. ET, 7:00 a.m. PT Dial-in number: 800-289-0498 Webcast of Call: A live webcast can be accessed online by going to: http://www.shareholder.com/ntii/medialist.cfm The call will be archived and accessible at the same website for one year Telephonic Replay: -- Playback of the conference call will be available from 1:30 p.m. ET on November 10, 2005 through 11:59 p.m. on November 18, 2005 -- Replay number: 888-203-1112 (U.S. and Canada) & 719-457-0820 (International) -- Replay access code: 9643014 About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer.

Neurobiological Technologies, Inc.

CONTACT: Paul E. Freiman, President & CEO, or Jonathan R. Wolter, VP andCFO, both of Neurobiological Technologies, Inc., +1-510-595-6000; orinvestors, Cheryl Schneider, VP, Investor Relations of Porter, Le Vay &Rose, Inc., +1-212-564-4700, for Neurobiological Technologies, Inc.

Back to news